Search research articles
Contact Us
Filters
Showing results (261-270 of 294) with videos related to
Page
of 30
Sort By:
Neuropharmacology
|
May 1, 1990
Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret
B Costall, A M Domeney, R J Naylor, et al.
Journal of Medicinal Chemistry
|
April 1, 1979
Rigid congeners of dopamine based on octahydrobenzo[f]quinoline: peripheral and central effects
J G Cannon, C Suarez-Gutierrez, T Lee, et al.
The Journal of Pharmacy and Pharmacology
|
August 1, 1980
On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms
B Costall, D H Fortune, F E Granchelli, et al.
Brain Research Bulletin
|
July 1, 1990
The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex
N M Barnes, B Costall, P Egli, et al.
Neuroscience Letters
|
October 24, 1985
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety
A J Bradbury, B Costall, A M Domeney, et al.
Neuropharmacology
|
August 1, 1991
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue
N M Barnes, B Costall, P Egli, et al.
Nature
|
January 2, 1986
1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway
A J Bradbury, B Costall, A M Domeney, et al.
British Journal of Pharmacology
|
April 1, 1988
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist
B J Jones, B Costall, A M Domeney, et al.
Pharmacology, Biochemistry, and Behavior
|
May 1, 1990
Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset
B Costall, A M Domeney, P A Gerrard, et al.
British Journal of Pharmacology
|
February 1, 1992
Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands
J M Barnes, N M Barnes, B Costall, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 294) with videos related to
Sort By:
Page
of 30
Neuropharmacology
|
May 1, 1990
Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret
B Costall, A M Domeney, R J Naylor, et al.
Journal of Medicinal Chemistry
|
April 1, 1979
Rigid congeners of dopamine based on octahydrobenzo[f]quinoline: peripheral and central effects
J G Cannon, C Suarez-Gutierrez, T Lee, et al.
The Journal of Pharmacy and Pharmacology
|
August 1, 1980
On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms
B Costall, D H Fortune, F E Granchelli, et al.
Brain Research Bulletin
|
July 1, 1990
The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex
N M Barnes, B Costall, P Egli, et al.
Neuroscience Letters
|
October 24, 1985
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety
A J Bradbury, B Costall, A M Domeney, et al.
Neuropharmacology
|
August 1, 1991
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue
N M Barnes, B Costall, P Egli, et al.
Nature
|
January 2, 1986
1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway
A J Bradbury, B Costall, A M Domeney, et al.
British Journal of Pharmacology
|
April 1, 1988
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist
B J Jones, B Costall, A M Domeney, et al.
Pharmacology, Biochemistry, and Behavior
|
May 1, 1990
Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset
B Costall, A M Domeney, P A Gerrard, et al.
British Journal of Pharmacology
|
February 1, 1992
Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands
J M Barnes, N M Barnes, B Costall, et al.
Page
of 30